Using magnetic resonance imaging to measure head muscles: An innovative method to opportunistically determine muscle mass and detect sarcopenia

Background Sarcopenia is associated with multiple adverse outcomes. Traditional methods to determine low muscle mass for the diagnosis of sarcopenia are mainly based on dual-energy X-ray absorptiometry (DXA), whole-body magnetic resonance imaging (MRI) and bioelectrical impedance analysis. These tes...

Full description

Bibliographic Details
Authors: Borda-Borda, M.G. (Miguel German)|||/items/681ecdf1-0f23-4003-a702-417198fd228d, Duque, G. (Gustavo)|||/items/be10365b-0620-4d45-8661-abf8414e2ec0, Pérez-Zepeda, M.U. (Mario Ulises)|||/items/fd0c6e2f-d3fe-4434-9b2d-156fc1f553e8, Patricio-Baldera, J. (Jonathan)|||/items/84267bf9-773b-43f0-a6c5-f6b7d4c81f2c, Westman, E. (Eric)|||/items/f4409478-415d-4ff2-aae4-cec5435233e6, Zettergren, A. (Anna)|||/items/b796e0ae-b9e0-4795-9b97-b8efc059ae65, Samuelsson, J. (Jessica)|||/items/fc86bc4e-5d3d-46e2-a70d-7aa197ac7290, Kern, S. (Silke)|||/items/aa021ecf-34bd-4a3a-aafe-312bb654c850, Rydén, L. (Lina)|||/items/28cc3927-2083-4238-b2c0-13c67afa39db, Skoog, I. (Ingmar)|||/items/acb900f6-c529-43ff-a582-324cf82f652c, Aarsland, D. (Dag)|||/items/7f4024e7-2d11-43cf-8b41-29752ddf75e1
Format: article
Publication Date:2023
Country:España
Institution:Universidad de Navarra
Repository:Dadun. Depósito Académico Digital de la Universidad de Navarra
Language:English
OAI Identifier:oai:dadun.unav.edu:10171/121800
Online Access:https://hdl.handle.net/10171/121800
Access Level:Open access
Keyword:dementia
diagnosis
geriatrics
H70
neurodegenerative disorders
sarcopenia
id ES_4da6f4eae2eaeb46adeba0c7427173aa
oai_identifier_str oai:dadun.unav.edu:10171/121800
network_acronym_str ES
network_name_str España
repository_id_str
spelling Using magnetic resonance imaging to measure head muscles: An innovative method to opportunistically determine muscle mass and detect sarcopeniaBorda-Borda, M.G. (Miguel German)|||/items/681ecdf1-0f23-4003-a702-417198fd228dDuque, G. (Gustavo)|||/items/be10365b-0620-4d45-8661-abf8414e2ec0Pérez-Zepeda, M.U. (Mario Ulises)|||/items/fd0c6e2f-d3fe-4434-9b2d-156fc1f553e8Patricio-Baldera, J. (Jonathan)|||/items/84267bf9-773b-43f0-a6c5-f6b7d4c81f2cWestman, E. (Eric)|||/items/f4409478-415d-4ff2-aae4-cec5435233e6Zettergren, A. (Anna)|||/items/b796e0ae-b9e0-4795-9b97-b8efc059ae65Samuelsson, J. (Jessica)|||/items/fc86bc4e-5d3d-46e2-a70d-7aa197ac7290Kern, S. (Silke)|||/items/aa021ecf-34bd-4a3a-aafe-312bb654c850Rydén, L. (Lina)|||/items/28cc3927-2083-4238-b2c0-13c67afa39dbSkoog, I. (Ingmar)|||/items/acb900f6-c529-43ff-a582-324cf82f652cAarsland, D. (Dag)|||/items/7f4024e7-2d11-43cf-8b41-29752ddf75e1dementiadiagnosisgeriatricsH70neurodegenerative disorderssarcopeniaBackground Sarcopenia is associated with multiple adverse outcomes. Traditional methods to determine low muscle mass for the diagnosis of sarcopenia are mainly based on dual-energy X-ray absorptiometry (DXA), whole-body magnetic resonance imaging (MRI) and bioelectrical impedance analysis. These tests are not always available and are rather time consuming and expensive. However, many brain and head diseases require a head MRI. In this study, we aim to provide a more accessible way to detect sarcopenia by comparing the traditional method of DXA lean mass estimation versus the tongue and masseter muscle mass assessed in a standard brain MRI. Methods The H70 study is a longitudinal study of older people living in Gothenburg, Sweden. In this cross-sectional analysis, from 1203 participants aged 70 years at baseline, we included 495 with clinical data and MRI images available. We used the appendicular lean soft tissue index (ALSTI) in DXA images as our reference measure of lean mass. Images from the masseter and tongue were analysed and segmented using 3D Slicer. For the statistical analysis, the Spearman correlation coefficient was used, and concordance was estimated with the Kappa coefficient. Results The final sample consisted of 495 participants, of which 52.3% were females. We found a significant correlation coefficient between both tongue (0.26) and masseter (0.33) with ALSTI (P < 0.001). The sarcopenia prevalence confirmed using the alternative muscle measure in MRI was calculated using the ALSTI (tongue = 2.0%, masseter = 2.2%, ALSTI = 2.4%). Concordance between sarcopenia with masseter and tongue versus sarcopenia with ALSTI as reference has a Kappa of 0.989 (P < 0.001) for masseter and a Kappa of 1 for the tongue muscle (P < 0.001). Comorbidities evaluated with the Cumulative Illness Rating Scale were significantly associated with all the muscle measurements: ALSTI (odds ratio [OR] 1.16, 95% confidence interval [CI] 1.07–1.26, P < 0.001), masseter (OR 1.16, 95% CI 1.07–1.26, P < 0.001) and tongue (OR 1.13, 95% CI 1.04–1.22, P = 0.002); the higher the comorbidities, the higher the probability of having abnormal muscle mass. Conclusions ALSTI was significantly correlated with tongue and masseter muscle mass. When performing the sarcopenia diagnostic algorithm, the prevalence of sarcopenia calculated with head muscles did not differ from sarcopenia calculated using DXA, and almost all participants were correctly classified using both methods.WileyDadun. Depósito Académico Digital Universidad de Navarra20232023-01-0120232023-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10171/121800reponame:Dadun. Depósito Académico Digital de la Universidad de Navarrainstname:Universidad de NavarraInglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:dadun.unav.edu:10171/1218002026-06-21T12:47:57Z
dc.title.none.fl_str_mv Using magnetic resonance imaging to measure head muscles: An innovative method to opportunistically determine muscle mass and detect sarcopenia
title Using magnetic resonance imaging to measure head muscles: An innovative method to opportunistically determine muscle mass and detect sarcopenia
spellingShingle Using magnetic resonance imaging to measure head muscles: An innovative method to opportunistically determine muscle mass and detect sarcopenia
Borda-Borda, M.G. (Miguel German)|||/items/681ecdf1-0f23-4003-a702-417198fd228d
dementia
diagnosis
geriatrics
H70
neurodegenerative disorders
sarcopenia
title_short Using magnetic resonance imaging to measure head muscles: An innovative method to opportunistically determine muscle mass and detect sarcopenia
title_full Using magnetic resonance imaging to measure head muscles: An innovative method to opportunistically determine muscle mass and detect sarcopenia
title_fullStr Using magnetic resonance imaging to measure head muscles: An innovative method to opportunistically determine muscle mass and detect sarcopenia
title_full_unstemmed Using magnetic resonance imaging to measure head muscles: An innovative method to opportunistically determine muscle mass and detect sarcopenia
title_sort Using magnetic resonance imaging to measure head muscles: An innovative method to opportunistically determine muscle mass and detect sarcopenia
dc.creator.none.fl_str_mv Borda-Borda, M.G. (Miguel German)|||/items/681ecdf1-0f23-4003-a702-417198fd228d
Duque, G. (Gustavo)|||/items/be10365b-0620-4d45-8661-abf8414e2ec0
Pérez-Zepeda, M.U. (Mario Ulises)|||/items/fd0c6e2f-d3fe-4434-9b2d-156fc1f553e8
Patricio-Baldera, J. (Jonathan)|||/items/84267bf9-773b-43f0-a6c5-f6b7d4c81f2c
Westman, E. (Eric)|||/items/f4409478-415d-4ff2-aae4-cec5435233e6
Zettergren, A. (Anna)|||/items/b796e0ae-b9e0-4795-9b97-b8efc059ae65
Samuelsson, J. (Jessica)|||/items/fc86bc4e-5d3d-46e2-a70d-7aa197ac7290
Kern, S. (Silke)|||/items/aa021ecf-34bd-4a3a-aafe-312bb654c850
Rydén, L. (Lina)|||/items/28cc3927-2083-4238-b2c0-13c67afa39db
Skoog, I. (Ingmar)|||/items/acb900f6-c529-43ff-a582-324cf82f652c
Aarsland, D. (Dag)|||/items/7f4024e7-2d11-43cf-8b41-29752ddf75e1
author Borda-Borda, M.G. (Miguel German)|||/items/681ecdf1-0f23-4003-a702-417198fd228d
author_facet Borda-Borda, M.G. (Miguel German)|||/items/681ecdf1-0f23-4003-a702-417198fd228d
Duque, G. (Gustavo)|||/items/be10365b-0620-4d45-8661-abf8414e2ec0
Pérez-Zepeda, M.U. (Mario Ulises)|||/items/fd0c6e2f-d3fe-4434-9b2d-156fc1f553e8
Patricio-Baldera, J. (Jonathan)|||/items/84267bf9-773b-43f0-a6c5-f6b7d4c81f2c
Westman, E. (Eric)|||/items/f4409478-415d-4ff2-aae4-cec5435233e6
Zettergren, A. (Anna)|||/items/b796e0ae-b9e0-4795-9b97-b8efc059ae65
Samuelsson, J. (Jessica)|||/items/fc86bc4e-5d3d-46e2-a70d-7aa197ac7290
Kern, S. (Silke)|||/items/aa021ecf-34bd-4a3a-aafe-312bb654c850
Rydén, L. (Lina)|||/items/28cc3927-2083-4238-b2c0-13c67afa39db
Skoog, I. (Ingmar)|||/items/acb900f6-c529-43ff-a582-324cf82f652c
Aarsland, D. (Dag)|||/items/7f4024e7-2d11-43cf-8b41-29752ddf75e1
author_role author
author2 Duque, G. (Gustavo)|||/items/be10365b-0620-4d45-8661-abf8414e2ec0
Pérez-Zepeda, M.U. (Mario Ulises)|||/items/fd0c6e2f-d3fe-4434-9b2d-156fc1f553e8
Patricio-Baldera, J. (Jonathan)|||/items/84267bf9-773b-43f0-a6c5-f6b7d4c81f2c
Westman, E. (Eric)|||/items/f4409478-415d-4ff2-aae4-cec5435233e6
Zettergren, A. (Anna)|||/items/b796e0ae-b9e0-4795-9b97-b8efc059ae65
Samuelsson, J. (Jessica)|||/items/fc86bc4e-5d3d-46e2-a70d-7aa197ac7290
Kern, S. (Silke)|||/items/aa021ecf-34bd-4a3a-aafe-312bb654c850
Rydén, L. (Lina)|||/items/28cc3927-2083-4238-b2c0-13c67afa39db
Skoog, I. (Ingmar)|||/items/acb900f6-c529-43ff-a582-324cf82f652c
Aarsland, D. (Dag)|||/items/7f4024e7-2d11-43cf-8b41-29752ddf75e1
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Dadun. Depósito Académico Digital Universidad de Navarra
dc.subject.none.fl_str_mv dementia
diagnosis
geriatrics
H70
neurodegenerative disorders
sarcopenia
topic dementia
diagnosis
geriatrics
H70
neurodegenerative disorders
sarcopenia
description Background Sarcopenia is associated with multiple adverse outcomes. Traditional methods to determine low muscle mass for the diagnosis of sarcopenia are mainly based on dual-energy X-ray absorptiometry (DXA), whole-body magnetic resonance imaging (MRI) and bioelectrical impedance analysis. These tests are not always available and are rather time consuming and expensive. However, many brain and head diseases require a head MRI. In this study, we aim to provide a more accessible way to detect sarcopenia by comparing the traditional method of DXA lean mass estimation versus the tongue and masseter muscle mass assessed in a standard brain MRI. Methods The H70 study is a longitudinal study of older people living in Gothenburg, Sweden. In this cross-sectional analysis, from 1203 participants aged 70 years at baseline, we included 495 with clinical data and MRI images available. We used the appendicular lean soft tissue index (ALSTI) in DXA images as our reference measure of lean mass. Images from the masseter and tongue were analysed and segmented using 3D Slicer. For the statistical analysis, the Spearman correlation coefficient was used, and concordance was estimated with the Kappa coefficient. Results The final sample consisted of 495 participants, of which 52.3% were females. We found a significant correlation coefficient between both tongue (0.26) and masseter (0.33) with ALSTI (P < 0.001). The sarcopenia prevalence confirmed using the alternative muscle measure in MRI was calculated using the ALSTI (tongue = 2.0%, masseter = 2.2%, ALSTI = 2.4%). Concordance between sarcopenia with masseter and tongue versus sarcopenia with ALSTI as reference has a Kappa of 0.989 (P < 0.001) for masseter and a Kappa of 1 for the tongue muscle (P < 0.001). Comorbidities evaluated with the Cumulative Illness Rating Scale were significantly associated with all the muscle measurements: ALSTI (odds ratio [OR] 1.16, 95% confidence interval [CI] 1.07–1.26, P < 0.001), masseter (OR 1.16, 95% CI 1.07–1.26, P < 0.001) and tongue (OR 1.13, 95% CI 1.04–1.22, P = 0.002); the higher the comorbidities, the higher the probability of having abnormal muscle mass. Conclusions ALSTI was significantly correlated with tongue and masseter muscle mass. When performing the sarcopenia diagnostic algorithm, the prevalence of sarcopenia calculated with head muscles did not differ from sarcopenia calculated using DXA, and almost all participants were correctly classified using both methods.
publishDate 2023
dc.date.none.fl_str_mv 2023
2023-01-01
2023
2023-01-01
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/10171/121800
url https://hdl.handle.net/10171/121800
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:Dadun. Depósito Académico Digital de la Universidad de Navarra
instname:Universidad de Navarra
instname_str Universidad de Navarra
reponame_str Dadun. Depósito Académico Digital de la Universidad de Navarra
collection Dadun. Depósito Académico Digital de la Universidad de Navarra
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869407705891864576
score 15,811543